Gemfibrozil and clofibrate in the treatment of hyperlipidaemias. A comparative trial.
作者信息
Eisalo A, Manninen V
出版信息
Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):44-6. doi: 10.1177/00359157760690S211.
Abstract
摘要
相似文献
1
Gemfibrozil and clofibrate in the treatment of hyperlipidaemias. A comparative trial.吉非贝齐和氯贝丁酯治疗高脂血症的比较试验。
Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):44-6. doi: 10.1177/00359157760690S211.
2
A long-term trial of gemfibrozil in the treatment of hyperlipidaemias.吉非贝齐治疗高脂血症的长期试验。
Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):49-52. doi: 10.1177/00359157760690S213.
3
A clofibrate controlled trial of gemfibrozil in the treatment of hyperlipidaemias.吉非贝齐治疗高脂血症的氯贝丁酯对照试验。
Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):38-40. doi: 10.1177/00359157760690S209.
4
Evaluation of increasing doses of gemfibrozil in hyperlipoproteinaemia.吉非贝齐递增剂量治疗高脂蛋白血症的评估。
Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):71-5. doi: 10.1177/00359157760690S217.
5
Gemfibrozil treatment: a comparison with clofibrate.
Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):88-9. doi: 10.1177/00359157760690S222.
6
Gemfibrozil as a lipid lowering compound in hyperlipoproteinaemia. A placebo-controlled cross-over trial.吉非贝齐作为高脂血症的降脂化合物。一项安慰剂对照交叉试验。
Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):32-7. doi: 10.1177/00359157760690S208.
7
The use of gemfibrozil in the treatment of primary hyperlipoproteinaemia. Preliminary report.
Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):78-9. doi: 10.1177/00359157760690S219.
8
The evaluation of lipoprotein changes during gemfibrozil treatment.吉非贝齐治疗期间脂蛋白变化的评估。
Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):76-7. doi: 10.1177/00359157760690S218.
9
Summary of present data from a clinical trial of CI-719.CI-719临床试验的当前数据总结。
Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):90-3. doi: 10.1177/00359157760690S223.
10
CI-719 in hyperlipoproteinaemia: interim data.
Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):83-7. doi: 10.1177/00359157760690S221.
引用本文的文献
1
Gemfibrozil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in dyslipidaemia.吉非贝齐。对其药效学和药代动力学特性以及在血脂异常治疗中的应用综述。
Drugs. 1988 Sep;36(3):314-39. doi: 10.2165/00003495-198836030-00004.
本文引用的文献
1
Long-term effects of clofibrate (Atromid-S) on serum lipids in man.氯贝丁酯（安妥明）对人体血脂的长期影响。
Circulation. 1969 May;39(5):675-83. doi: 10.1161/01.cir.39.5.675.
2
Physical hazards.物理危害。
Postgrad Med J. 1975;51 Suppl 2:suppl 51: 5-9.
Zotero 插件